Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

October 1, 2002; Volume 43,Issue 10
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Lammertsma, Adriaan A.

    1. You have access
      Methods to Monitor Response to Chemotherapy in Non-Small Cell Lung Cancer with 18F-FDG PET
      Corneline J. Hoekstra, Otto S. Hoekstra, Sigrid G. Stroobants, Johan Vansteenkiste, Johan Nuyts, Egbert F. Smit, Maarten Boers, Jos W.R. Twisk and Adriaan A. Lammertsma
      Journal of Nuclear Medicine October 1, 2002, 43 (10) 1304-1309;
  2. Logan, Jean

    1. You have access
      PET Imaging of Monoamine Oxidase B in Peripheral Organs in Humans
      Joanna S. Fowler, Jean Logan, Gene-Jack Wang, Nora D. Volkow, Wei Zhu, Dinko Franceschi, Naomi Pappas, Richard Ferrieri, Colleen Shea, Victor Garza, Youwen Xu, Robert R. MacGregor, David Schlyer, S. John Gatley, Yu-Shin Ding and David Alexoff
      Journal of Nuclear Medicine October 1, 2002, 43 (10) 1331-1338;
  3. Lubberink, Mark

    1. You have access
      110mIn-DTPA-d-Phe1-Octreotide for Imaging of Neuroendocrine Tumors with PET
      Mark Lubberink, Vladimir Tolmachev, Charles Widström, Alexander Bruskin, Hans Lundqvist and Jan-Erik Westlin
      Journal of Nuclear Medicine October 1, 2002, 43 (10) 1391-1397;
  4. Lundqvist, Hans

    1. You have access
      110mIn-DTPA-d-Phe1-Octreotide for Imaging of Neuroendocrine Tumors with PET
      Mark Lubberink, Vladimir Tolmachev, Charles Widström, Alexander Bruskin, Hans Lundqvist and Jan-Erik Westlin
      Journal of Nuclear Medicine October 1, 2002, 43 (10) 1391-1397;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 43 (10)
Journal of Nuclear Medicine
Vol. 43, Issue 10
October 1, 2002
  • Table of Contents
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire